2021 Volume 10 Issue 2
Creative Commons License

An Overview on Diagnosis and Management of Non-alcoholic Fatty Liver Disease


, , , , , , , , , ,
Abstract

Non-alcoholic fatty liver disease (NAFLD) is difficult to define, has intricate pathogenesis, has a high outbreak, and few acquiesced treatments are available. Thus, this condition has posed a great challenge in our time. The non-alcoholic fatty liver disorder is correlated with obesity and insulin resistance and is emerging as the most ordinary form of chronic liver disorder in grown-ups and kids alike. The Pubmed, NCBI, Medline, Cochrane databases, and Embase were searched for patients' studies with nonalcoholic fatty liver disorder. Management options, Incidence, and causes were all investigated. NAFLD is a quickly rising reason for a chronic liver disorder. It is a complicated condition that encounters multiple challenges in its management and assessment. If it's not treated on time, hepatic steatosis may progress to NASH and eventually liver cirrhosis. Controlling this illness requires a multidisciplinary technique. We hope that treatment options for advanced stages of the condition will meliorate in the next decade.


How to cite this article
Vancouver
Wedaatella AF, Almehery RA, Namar RMA, Shmashir ASM, Alhouda AMA, Fallatah AA, et al. An Overview on Diagnosis and Management of Non-alcoholic Fatty Liver Disease. Int J Pharm Res Allied Sci. 2021;10(2):144-8. https://doi.org/10.51847/QKKcVYgTBX
APA
Wedaatella, A. F., Almehery, R. A., Namar, R. M. A., Shmashir, A. S. M., Alhouda, A. M. A., Fallatah, A. A., Osman, A. A. A., Alazmi, N. H. A., Hurubi, M. A. M., Al Khuraidah, Z. A., et al. (2021). An Overview on Diagnosis and Management of Non-alcoholic Fatty Liver Disease. International Journal of Pharmaceutical Research and Allied Sciences, 10(2), 144-148. https://doi.org/10.51847/QKKcVYgTBX
Issue 1 Volume 14 (2025)